Emergency. 2017; 5 (1): e81 http://dx.doi.org/10.22037/emergency.v5i1.18805 OR I G I N A L RE S E A RC H Valsalva maneuver Using a Handmade Device in Supraventricular Tachycardia Reversion; a Quasi Experi- mental Study Maryam Motamedi1, Mohammad Ali Akbarzadeh2, Saeed Safari1, Mehrnoosh Shahhoseini1∗ 1. Emergency Department, Shohadaye Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran. 2. Cardiovascular Research Center, Modarres Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Received: September 2017; Accepted: October 2017; Published online: 15 October 2017 Abstract: Introduction: The use of vagal nerve stimulation is identified as a proper treatment option in patients with stable supraventricular tachycardia (SVT). This study aimed to assess the success of Valsalva maneuver via a handmade device in reversion of SVT. Methods: In this quasi experimental study, using a handmade device, vagus nerve stimulation was performed for SVT patients presenting to emergency department or cardiac inter- vention unit and the success rate and its related factors were assessed. Results: 100 patients with the mean age of 53.05 ± 13.70 years were studied (67% female). 12 (12%) cases were unable to do the maneuver. Out of the 88 (88.0%) patients who could perform the maneuver, 75 (85.2%) cases were unsuccessful. Dysrhythmia was con- trolled in 6 (6.8%) cases on the first attempt and in 7 (8.0%) cases on the second one (14.8% total success rate). 12 of the 13 cases (92.3%) of successful maneuver had history of SVT (p = 0.031). There was not any significant association between success rate and sex (p = 0.084), age (p = 0.744), or other medical histories (p ≥ 0.05). Conclusion: Based on the results of the present study, the success rate of Valsalva maneuver with the mentioned handmade device was calculated to be 14.8%. The only independent related factor of successful reversion was SVT history. Keywords: Vagus nerve stimulation; Valsalva maneuver; tachycardia, supraventricular; arrhythmias, cardiac; emergency service, hospital © Copyright (2017) Shahid Beheshti University of Medical Sciences Cite this article as: Motamedi M, Akbarzadeh MA, Safari S, Shahhoseini M. Valsalva maneuver using a Handmade Device in Supraventricular Tachycardia Reversion; a Quasi Experimental Study. Emergency. 2017; 5(1): e81. 1. Introduction S upraventricular tachycardia (SVT) comprises a com- mon group of cardiac arrhythmia in patients referring to emergency departments. The overall incidence of this acute phenomenon has been estimated to be 35 cases per 100,000 patients (1). SVT symptoms are often non- specific, which include chest pain, shortness of breath, sense of palpitation, pounding in the neck, and even some degree of psychological disturbances such as anxiety (2). Impulse formation and impulse conduction processes may both be disturbed (3). In fact, three mechanisms of triggered activity, reentry, or ∗Corresponding Author: Mehrnoosh Shahhoseini; Emergency Department, Shohadaye Tajrish Hospital, Shardari Street, Tajrish Square, Tehran, Iran. Email: me.shahhoseini@gmail.com Tel: 00989123072482 increased automaticity with atrioventricular node source or above cardiac tissue source may be involved in SVT (4). Hence, the initial management of SVT involves slow atrioven- tricular node conduction by evolving pharmacological ap- proaches, mechanical maneuvers, or invasive approaches if required (5-14). The use of vagal maneuvers is now identified as a proper treatment option for patients with stable SVT but its success rate varies between 6% and 54% (15-19). There are different options for performing vagal maneuvers including the Val- salva maneuver and carotid sinus massage (20). However, there is no measurable and controlled method in this regard. The present study aimed to assess the success of Valsalva ma- neuver via a handmade device in reversion of SVT. This open-access article distributed under the terms of the Creative Commons Attribution NonCommercial 3.0 License (CC BY-NC 3.0). Downloaded from: www.jemerg.com M. Motamedi et al. 2 2. Methods 2.1. Study design and setting This quasi experimental multicenter study was performed from Oct 2014 to Oct 2016 at four general educational hos- pitals (Imam Hossein, Shohadaye Tajrish, Loghman Hakim, and Modarres Hospitals), Tehran, Iran. Using a handmade device, vagus stimulation was performed for patients pre- senting to emergency department or cardiac intervention unit following SVT. The study protocol was approved by ethics committee of Shahid Beheshti University of Medical Sciences. All researchers adhered to principles of Helsinki declaration and confidentiality of patients’ information. 2.2. Participants The study was conducted on patients >18 years old who con- secutively presented to emergency departments of the men- tioned hospitals with the initial evidence of SVT (n = 45) or were scheduled for inducing arrhythmia by a cardiologist at cardiac intervention unit (n = 55). Patients who were not able to perform the maneuver or did not give consent, those with hemodynamic instability, atrial fibrillation or flutter, malignant hypertension, or other contraindications for per- forming Valsalva maneuver (such as cerebral AVM, increased intraocular pressure, glaucoma, or third trimester of preg- nancy) were excluded. 2.3. Procedure For creating the Valsalva maneuver’s handmade device, the cuff of the sphygmomanometer was disconnected and the device’s pressure monitor was connected to a 90cm oxygen connector, and the end of connector was connected to a 10cc syringe (figure 1). Maneuver was performed at supine posi- tion and with 30 to 50 mmHg pressure for 15 seconds. If the first attempt was unsuccessful, another attempt was made after five minutes. In cases of unsuccessful reversion with two Valsalva maneuver, pharmacological approach was be- gun. During the maneuver performance, all required sup- portive instruments including intubation and defibrillation sets were available and the patients were under continuous cardiac and blood pressure monitoring. 2.4. Outcome Achieving sinus rhythm following the first or second maneu- ver attempt was considered as the main outcome of study (successful maneuver). 2.5. Statistical Analysis Results were presented as mean ± standard deviation (SD) or frequencies and percentages. Chi-square or Fisher’s exact tests and t test were used for comparisons. Data were ana- lyzed using SPSS 21 statistical software. P values of 0.05 or Figure 1: The handmade device used in the present study. Table 1: Baseline characteristics of the studied patients Variable Value Sex Female 67 (67) Male 33 (33) Age (year) 20 – 40 16 (16) 40 – 60 50 (50) ≥ 60 34 (34) Medical history Hypertension 17 (17) Diabetes mellitus 19 (19) Smoking 10 (10) Ischemic heart disease 17 (17) SVT 67 (67) Arrhythmias 6 (6) Calcium blocker use 11 (11) Beta blocker use 45 (45) Weight (kg) 73.8 ± 13.8 Height (cm) 165.0 ± 8.2 Heart rate (beats/minute) 173.3 ± 25.7 Data were presented as mean ± standard deviation or num- ber (%). SVT: Supraventricular tachycardia. less were considered statistically significant. 3. Results 3.1. Baseline characteristics 100 patients with the mean age of 53.05 ± 13.70 years (22 - 85) were studied (67% female). The baseline characteristics of the subjects are summarized in Table 1. Most patients were in the age range of 40 – 60 years and 67% of them had his- tory of SVT. SVT had resulted from atrio-ventricular nodal re- entrant tachycardia (AVNRT) in 59%, atrio-ventricular reen- trant tachycardia (AVRT) in 14%, and unknown origin in 27%. This open-access article distributed under the terms of the Creative Commons Attribution NonCommercial 3.0 License (CC BY-NC 3.0). Downloaded from: www.jemerg.com 3 Emergency. 2017; 5 (1): e81 3.2. Maneuver Outcome 12 (12%) cases were unable to do the maneuver. Out of the 88 (88.0%) patients who could perform the maneuver, 75 (85.2%) cases were unsuccessful. Dysrhythmia was con- trolled in 6 (6.8%) cases at the first attempt and in 7 (8.0%) cases at the second one (14.8% total success rate). 12 of the 13 cases (92.3%) of successful maneuver had history of SVT (p = 0.031). There was not any significant association be- tween success rate and sex (p = 0.084), age (p = 0.744), or other medical histories (p ≥ 0.05). Unable and unsuccessful cases were treated with ablation (52.9%), adenosine (40.4%), amiodarone (4.5%), and verapamil (2.2%). 4. Discussion Based on the results of the present study, the success rate of Valsalva maneuver with the introduced handmade device was estimated to be 14.8%. The only independent related fac- tor of successful reversion was SVT history. Along with med- ications and ablation, the use of vagal maneuvers has been introduced as an alternative modality leading to reversion of AVRT and AVNRT in up to 54% of affected patients (17, 21). Vagal maneuver can be the most successful method to re- verse arrhythmias if the maneuver is performed in supine position with adequate intra-thoracic pressure (at least 30 mmHg) for at least 15 seconds (22, 23). Despite considering all the mentioned conditions, the success rate of this maneu- ver has been considerably low in almost all studies. As shown in our study, the vagal maneuver was successful only in 14.8% of subjects. This rate was about 19.4% in the report by Lim et al. (17). However, in animal and laboratory-based studies as well as in the new modified version of Valsalva maneuver, the rate of reversion was shown to be in the range of 45.9% to 54.3% (1, 21). Taylor et al. showed that only few num- ber of physicians give enough instructions to their patients regarding the position, duration, pressure and other charac- teristics of maneuver (24). According to the second finding of our study, with respect to main determinants of the suc- cess of Valsalva maneuver to reverse SVT, none of the base- line characteristics, except for previous experiment of SVT, could predict high success rate for this maneuver. Higher success of this maneuver to terminate SVT in those with pre- vious SVT might be due to more careful and cautious perfor- mance of the maneuver by the specialists in this high risk group or more excitability of cardiac conductive system of those cases by inducing maneuver. It seems that, a major- ity of patients who suffer from SVT may not benefit from Val- salva maneuver and thus, employing the modified maneuver is more recommended. Higher success of this maneuver in patients with history of SVT requires more evaluation. There- fore, further studies with larger and heterogonous samples and proper follow up are recommended. 5. Limitation In this study, more than half of the participants were patients with induced arrhythmia by cardiologist, which may affect the response to treatment. 6. Conclusion Based on the results of the present study, the success rate of Valsalva maneuver with the mentioned handmade device was calculated to be 14.8%. The only independent related factor of successful reversion was SVT history. 7. Appendix 7.1. Acknowledgements This article is derived from Dr. Mehrnoosh Shahhoseini’s the- sis for achieving a specialist degree in the field of emergency medicine at Shahid Beheshti University of medical sciences. 7.2. Author contribution All authors passed four criteria for authorship contribution based on recommendations of the International Committee of Medical Journal Editors. 7.3. Funding/Support None. 7.4. Conflict of interest None. References 1. Orejarena LA, Vidaillet H, DeStefano F, Nordstrom DL, Vierkant RA, Smith PN, et al. Paroxysmal supraventricu- lar tachycardia in the general population. Journal of the American College of Cardiology. 1998;31(1):150-7. 2. Bibas L, Levi M, Essebag V. Diagnosis and management of supraventricular tachycardias. CMAJ: Canadian Med- ical Association journal= journal de l’Association medi- cale canadienne. 2016;188(17-18):E466. 3. Al-Zaiti SS, Magdic KS. Paroxysmal Supraventric- ular Tachycardia. Critical Care Nursing Clinics. 2016;28(3):309-16. 4. Rujic D, Sundboll J, Tofig B, Nielsen J, Pareek M. Initial evaluation and management of paroxysmal supraven- tricular tachycardia. Ugeskrift for laeger. 2016;178(3). 5. Sawan N, Eitel C, Thiele H. Ablation supraventrikularer Tachykardien. Herzschrittmachertherapie+ Elektrophys- iologie. 2016;27(2):143-50. 6. Page RL, Joglar JA, Caldwell MA, Calkins H, Conti JB, Deal BJ, et al. 2015 ACC/AHA/HRS guideline for the man- agement of adult patients with supraventricular tachy- This open-access article distributed under the terms of the Creative Commons Attribution NonCommercial 3.0 License (CC BY-NC 3.0). Downloaded from: www.jemerg.com M. Motamedi et al. 4 cardia. Journal of the American College of Cardiology. 2016;67(13):e27-e115. 7. Chun HM, Sung RJ. Supraventricular tachyarrhythmias: Pharrnacologic versus nonpharrnacologic approaches. Medical Clinics of North America. 1995;79(5):1121-34. 8. Scheinman M. Supraventricular tachyarrhythmias: drug therapy versus catheter ablation. Clinical cardiology. 1994;17(S2). 9. Waldo AL. An approach to therapy of supraventricular tachyarrhythmias: an algorithm versus individualized therapy. Clinical cardiology. 1994;17(S2). 10. Cheng C, Sanders G, Hlatky M, Heidenreich P, McDonald K, Lee B, et al. Cost-Effectiveness of Radiofrequency Ab- lation for Supraventricular Tachycardia. 2000. 11. Link MS. Evaluation and initial treatment of supraven- tricular tachycardia. New England Journal of Medicine. 2012;367(15):1438-48. 12. Holdgate A, Foo A. Adenosine versus intravenous cal- cium channel antagonists for the treatment of supraven- tricular tachycardia in adults. Cochrane Database Syst Rev. 2006;4. 13. Delaney B, Loy J, Kelly A-M. The relative efficacy of adenosine versus verapamil for the treatment of stable paroxysmal supraventricular tachycardia in adults: a meta-analysis. European Journal of Emergency Medicine. 2011;18(3):148-52. 14. Whinnett ZI, Sohaib SA, Davies DW. Diagnosis and management of supraventricular tachycardia. BMJ. 2012;345:e7769. 15. Waxman MB, Wald RW, Sharma AD, Huerta F, Cameron DA. Vagal techniques for termination of paroxysmal supraventricular tachycardia. The American journal of cardiology. 1980;46(4):655-64. 16. Wen Z-C, Chen S-A, Tai C-T, Chiang C-E, Chiou C- W, Chang M-S. Electrophysiological mechanisms and determinants of vagal maneuvers for termination of paroxysmal supraventricular tachycardia. Circulation. 1998;98(24):2716-23. 17. Lim S, Anantharaman V, Teo W, Goh P, Tan A. Comparison of treatment of supraventricular tachycardia by Valsalva maneuver and carotid sinus massage. Annals of emer- gency medicine. 1998;31(1):30-5. 18. Smith G. Management of supraventricular tachycardia using the Valsalva manoeuvre: a historical review and summary of published evidence. European Journal of Emergency Medicine. 2012;19(6):346-52. 19. Ferguson JD, DiMarco JP. Contemporary management of paroxysmal supraventricular tachycardia. Circulation. 2003;107(8):1096-9. 20. Sohinki D, Obel OA. Current trends in supraventric- ular tachycardia management. The Ochsner Journal. 2014;14(4):586-95. 21. Taylor DM, Auble TF, Yealy DM. First-line management of paroxysmal supraventricular tachycardia. The American journal of emergency medicine. 1999;17(2):214-6. 22. Looga R. The Valsalva manoeuvre–cardiovascular effects and performance technique: a critical review. Respira- tory physiology & neurobiology. 2005;147(1):39-49. 23. Waxman MB, Wald RW, Finley JP, Bonet JF, Downar E, Sharma AD. Valsalva termination of ventricular tachycar- dia. Circulation. 1980;62(4):843-51. 24. Taylor DM, Wong LF. Incorrect instruction in the use of the Valsalva manoeuvre for paroxysmal supra- ventricular tachycardia is common. Emergency Medicine Australasia. 2004;16(4):284-7. This open-access article distributed under the terms of the Creative Commons Attribution NonCommercial 3.0 License (CC BY-NC 3.0). Downloaded from: www.jemerg.com Introduction Methods Results Discussion Limitation Conclusion Appendix References